AP -- Alexion Pharmaceuticals Inc. said Wednesday it will start selling its blood disorder drug Soliris in Japan about three months earlier than it had expected.
AP -- Alexion Pharmaceuticals Inc. said Wednesday it will start selling its blood disorder drug Soliris in Japan about three months earlier than it had expected.
